Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ÍCARA)-Reference-Cited by-同舟云学术

Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ÍCARA)

Published:2019-09 Issue:05 Volume:51 Page:222
ISSN:1764-1489
Container-title:European Annals of Allergy and Clinical Immunology
language:
Short-container-title:Eur Ann Allergy Clin Immunol

Author:

Cuesta-Herranz J.¹,Laguna J.J.²,Mielgo R.³,Pérez-Camo I.⁴,Callejo A.M.⁵,Begoña L.⁶,Madariaga B.⁶,Gomez M.C.⁶,Martinez A.⁶

Affiliation:

1. IIS-Fundación Jiménez Díaz, Allergy Department, Madrid, Spain

2. Allergy Unit, Allergo-Anaesthesia Unit, Hospital Central de la Cruz Roja, Faculty of Medicine, Alfonso X El Sabio University, ARADyAL, Madrid, Spain

3. Hospital 12 de Octubre, Allergy Department, Madrid, Spain

4. Hospital Royo Villanova, Allergy Department, Zaragoza, Spain

5. Hospital Virgen de la Concha, Allergy Department, Zamora, Spain

6. ROXALL Medicina España S.A., R and D Department, Zamudio, Bizkaia, Spain

Publisher

Edra SpA

Subject

Immunology and Allergy

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of subcutaneous immunotherapy with polymerized allergen mixtures in polyallergic patients – ARES observational study;Expert Review of Clinical Immunology;2024-07-02

2. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06

3. Treatment with pollen allergen immunotherapy improves health-related quality of life in children and adolescents: a three-year follow-up-study;Allergy, Asthma & Clinical Immunology;2023-01-17

4. First‐in‐human phase 2 trial with mite allergoids coupled to mannan in subcutaneous and sublingual immunotherapy;Allergy;2022-05-27

5. Post-procedure Rhinitis After Use of Sedatives and Supplemental Nasal Oxygen;Cureus;2022-03-22